Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Columnists


Search by Name:

About Allan Jackson

Allan Jackson
Allan Jackson
Allan Jackson is a graduate of Dartmouth College, and a former investment banker with J.P Morgan. He currently works for J. Lazarow & Co., a private equity firm headquartered in New York.


Allan Jackson's Most Recent Articles

Auspicious developments at pharmaceutical company

Writer says Cellceutix Corp. has made what appears to be a breakthrough in oncology with its...

Allan Jackson | November 4, 2011

Micro cap biotech tackling autism treatment

Dark horse candidate developing a novel compound

Allan Jackson | July 15, 2010

3D technology delivers heart images quickly and on the cheap

Medical devices company has years of research, managerial expertise backing it.

Allan Jackson | March 11, 2010

Anti-viral compound could be developed for multiple usages

Micro-cap biotech company has "destructively innovative technology" and great management.

Allan Jackson | March 8, 2010

Steel maker ready to bring new mills into production

Mining and construction industry could use new super alloy

Allan Jackson | February 9, 2010

Biotech junior is baby blue chip

Management from major drug developers moves to nano-cap company with cancer drug in development.

Allan Jackson | September 21, 2009